Fig. 1
From: French recommendations for the management of systemic sclerosis
Recommendations for initial evaluation and follow-up of patients with systemic sclerosis. ACR American College of Rheumatology, EULAR European League Against Rheumatism, RNA ribonucleic acid, NYHA New York Heart Association, PFT pulmonary function tests, DLCO carbon monoxide diffusing capacity, ILD diffuse infiltrative lung disease, ECG electrocardiogram, NT-proBNP N-terminal pro b-type natriuretic peptide, MRI magnetic resonance imaging, PAH pulmonary arterial hypertension. *Risk of scleroderma renal crisis, **if cardiac damage is in doubt